Figure 8.
(A–C) Recombinant TM and infection with clinical isolate. Significantly different clinical scores (A) were seen at 3 but not 1 or 5 days p.i. in rTM- compared with PBS-treated mice infected with KEI 1025. Photographs taken with a slit lamp at 5 days p.i. showed similar opacity/disease after rTM (C) compared with PBS (B) treatment. Magnification (B, C) = ×6.5.